NCT00001839View on ClinicalTrials.gov

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

December 31, 1998

Study Completion Date

May 31, 2000

Conditions

Hematologic DiseasesMyelodysplastic Syndromes

Interventions

DRUG

Antithymocyte globulin

DRUG

Cyclosporine

Trial Locations (1)

20892

Warren G. Magnuson Clinical Center (CC), Bethesda

All Listed Sponsors

lead

National Institutes of Health Clinical Center (CC)

NIH